KR20140137244A - Feed composite for culturing leptocephalus - Google Patents
Feed composite for culturing leptocephalus Download PDFInfo
- Publication number
- KR20140137244A KR20140137244A KR1020130057929A KR20130057929A KR20140137244A KR 20140137244 A KR20140137244 A KR 20140137244A KR 1020130057929 A KR1020130057929 A KR 1020130057929A KR 20130057929 A KR20130057929 A KR 20130057929A KR 20140137244 A KR20140137244 A KR 20140137244A
- Authority
- KR
- South Korea
- Prior art keywords
- egg
- leptocephalus
- eggs
- fish
- feed
- Prior art date
Links
- 241000522084 Leptocephalus Species 0.000 title claims abstract description 8
- 239000002131 composite material Substances 0.000 title 1
- 238000012258 culturing Methods 0.000 title 1
- 241000251468 Actinopterygii Species 0.000 claims abstract description 38
- 235000013601 eggs Nutrition 0.000 claims abstract description 32
- 239000013505 freshwater Substances 0.000 claims abstract description 23
- 235000007882 dietary composition Nutrition 0.000 claims abstract description 17
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 13
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 13
- 230000000694 effects Effects 0.000 claims abstract description 11
- 238000010438 heat treatment Methods 0.000 claims abstract description 10
- 108091005804 Peptidases Proteins 0.000 claims abstract description 8
- 239000004365 Protease Substances 0.000 claims abstract description 8
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 8
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000014103 egg white Nutrition 0.000 claims abstract description 6
- 210000000969 egg white Anatomy 0.000 claims abstract description 6
- 241000239366 Euphausiacea Species 0.000 claims abstract description 5
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims abstract description 5
- 102000004856 Lectins Human genes 0.000 claims abstract description 5
- 108090001090 Lectins Proteins 0.000 claims abstract description 5
- 239000002523 lectin Substances 0.000 claims abstract description 5
- 235000002949 phytic acid Nutrition 0.000 claims abstract description 5
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 4
- 229940068041 phytic acid Drugs 0.000 claims abstract description 4
- 239000000467 phytic acid Substances 0.000 claims abstract description 4
- 210000003278 egg shell Anatomy 0.000 claims description 7
- 238000009360 aquaculture Methods 0.000 claims description 6
- 244000144974 aquaculture Species 0.000 claims description 6
- 241000238557 Decapoda Species 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 239000003221 ear drop Substances 0.000 claims 1
- 229940047652 ear drops Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 229940088594 vitamin Drugs 0.000 abstract description 6
- 229930003231 vitamin Natural products 0.000 abstract description 6
- 235000013343 vitamin Nutrition 0.000 abstract description 6
- 239000011782 vitamin Substances 0.000 abstract description 6
- 241000269796 Seriola quinqueradiata Species 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 238000004108 freeze drying Methods 0.000 abstract description 2
- 239000012528 membrane Substances 0.000 abstract description 2
- 241000894007 species Species 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract 5
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 241000251730 Chondrichthyes Species 0.000 description 7
- 230000012447 hatching Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 230000004083 survival effect Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000002969 egg yolk Anatomy 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 230000000384 rearing effect Effects 0.000 description 4
- 241000252071 Anguillidae Species 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 235000013345 egg yolk Nutrition 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 108010011619 6-Phytase Proteins 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 208000007623 Lordosis Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 244000078703 ectoparasite Species 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 229940064302 folacin Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000005996 muscular dysfunction Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 206010039722 scoliosis Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 210000004894 snout Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 230000030968 tissue homeostasis Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/10—Culture of aquatic animals of fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Environmental Sciences (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Health & Medical Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Biodiversity & Conservation Biology (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Farming Of Fish And Shellfish (AREA)
Abstract
Description
본 발명은 민물뱀장어 자어의 양식에 적합한 식이조성물에 관한 것으로, 보다 상세하게는 민물뱀장어 자어의 양식에 적용되도록 함으로써 양호한 인공종묘(치어)를 확보하여 대량 양식이 가능하도록 하기 위한 민물뱀장어 자어의 양식에 적합한 식이조성물에 관한 것이다.The present invention relates to a dietary composition suitable for the culture of freshwater eel fish, and more particularly, to a fishery composition for freshwater eel fish which is adapted to the culture of freshwater eel fish to provide good artificial nursery (fry) ≪ / RTI >
일반적으로, 극동산 민물뱀장어는 태평양의 심해(深海)(남태평양 마리아나 제도의 서부 근해로 추정)에서 부화하여 렙토세팔루스(즉, 민물뱀장어의 자어 또는 유어)의 형태로 북적도 해류를 따라 서향으로 이동하다가 쿠로시오 해류를 따라 북향으로 이동하게 되고, 연안에 도달하면서 실뱀장어(즉, 민물뱀장어 치어)로 변태하여 강이나 하천 또는 저수지로 소상하여 성장하다가 산란을 위해 다시 태평양의 심해 지역으로 회유하는 생태적 특성을 갖게 된다.In general, the Far East freshwater eels hatch in the deep sea of the Pacific Ocean (estimated to be the western margin of the Mariana Islands in the South Pacific) and migrate westward along the boreal currents in the form of leptosepalus (ie, freshwater eel fish) It travels northward along the Kuroshio Current, and as it reaches the coast, it transforms into an eel (ie freshwater eel) and grows into a river, a river, or a reservoir. It then echoes back to the deep- .
그러한 민물뱀장어는 생산량이 많은 중요한 양식 어종이지만, 그 종묘는 전부 천연의 치어에 의존하는 실정으로, 민물뱀장어의 양식은 난생부화된 자어로서의 렙토세팔루스가 변태하여 강이나 하천 또는 저수지로 소상하기 위해 회유하는 실뱀장어를 포획하여 성어로 성장시키는 고부가 가치의 산업이지만, 실뱀장어(치어)의 어획량에 따라 양식비용의 변동이 심해질 수 밖에 없고, 근래에는 환경의 오염이나 훼손 등에 기인하여 천연 자원의 고갈이 염려되는 상황이다.Such freshwater eels are important production fish species, but their seeds are all dependent on natural fry, and freshwater eel culture is a form of reptose saplings that grows into a river, river or reservoir It is a high-value-added industry that captures migratory eel fishes and grows them as sexually harvested fish. However, fluctuations in farming costs are inevitably accompanied by catches of eel fishes (cheerleaders). In recent years, depletion of natural resources This is a situation that is concerned.
그러한 이유로, 최근에는 친어로부터 인공적으로 채란 및 부화시켜 유생기(렙토세팔루스)를 거쳐 치어로 변태시키고 그 치어를 성어로 성장시키기 위한 완전한 양식체계를 확립하기 위한 다양한 시도가 진행되는 상황으로, 천연에서 채취한 치어로부터 친어의 육성, 인공산란, 인공부화까지는 성공한 상태이지만 인공부화 후의 자어가 치어기(稚魚期)로 되기까지의 사이에 상당 수가 사멸되어버리기 때문에 민물뱀장어 양식사업에 커다란 장애로 되고 있다.For this reason, in recent years, attempts have been made to establish a complete aquaculture system for artificially growing and hatching from a spermatozoa, transforming it into a fry via a serpentine (Leptosepalus) From the fished fish to the breeding, artificial spawning, and artificial hatching of the broodstock. However, since the larvae of artificial hatching are largely killed during the incubation period, they become a major obstacle to the freshwater eel culture have.
또, 난생 부화한 직후의 프레렙토세팔루스는 모태의 난황(卵黃)을 영양원으로 하고 부화 후 대략 8∼9일이 경과되면 식이(食餌)섭취활동을 개시하게 되지만, 현재까지는 자연 환경 하에서 친어의 산란과정에서부터 치어로의 변태과정이 정확하게 알려지지 않은 상태이기 때문에, 실제 변태된 민물뱀장어 치어에 대한 최적의 식이조성물에 대한 개발이 활발하게 진행되는 추세이다.Pretreptosepalus immediately after hatching of hatchlings is fed with egg yolk of mother hatchlings as a nutrient source, and when approximately 8 to 9 days have elapsed after hatching, the dietary hatching activity is initiated. However, until now, Since the transformation process from the spawning process to the fry is not known precisely, development of optimal dietary composition for the actual transformed freshwater eel fish is progressing actively.
본 발명은 상기한 종래 기술의 사정을 감안하여 이루어진 것으로, 민물뱀장어 자어가 연안으로 이동하는 경로에 서식하는 어류의 어란(魚卵)내용물에 대해 가열처리 또는 소정의 억제제를 사용하여 단백질분해효소인 '프로테아제(Protease)의 활성을 저하시켜 상어(곱상어)의 난황을 사용하지 않고도 민물뱀장어 자어인 '렙토세팔루스'의 성장 및 생잔가능성을 증진시키도록 된 민물뱀장어 자어의 양식에 적합한 식이조성물을 제공함에 그 목적이 있다.SUMMARY OF THE INVENTION The present invention has been made in view of the circumstances of the prior art described above, and it is an object of the present invention to provide a method for producing a fish meal, which comprises the step of applying a heat treatment or a predetermined inhibitor to a fish egg content of a fish living in the pathway of freshwater eel- 'A dietary composition suitable for the culture of freshwater eel' s eardrill, which promotes the growth and survivability of 'freshwater eel' reptosaeparose without decreasing the activity of protease and using the egg yolk of shark The purpose is to provide.
상기한 목적을 달성하기 위해, 본 발명의 바람직한 실시예에 따르면 민물뱀장어의 자어(Leptocephalus)를 양식수조에 수용한 상태에서 급식되는 민물뱀장어의 식이조성물(사료)에 있어서, 상기 식이조성물은 상기 자어가 연안으로 이동하는 해류의 범위에 서식하는 어종으로서의 방어의 어란을 파쇄하고 필터링하여 난막을 제거하여 얻어진 어란내용물에 종합비타민과 계란의 난백(卵白) 및 크릴새우 추출물을 혼합하여 급속냉동 건조시켜서 이루어진 민물뱀장어 자어의 분말사료가 제공된다.To achieve the above object, according to a preferred embodiment of the present invention, there is provided a dietary composition (feedstuff) of freshwater eel which is fed while containing Leptocephalus of freshwater eel in a culture water tank, , Which is a fish species in the range of the ocean current moving to the coast, is crushed and filtered to remove the egg shell, and the resultant vitamins are mixed with eggs egg white and krill shrimp extracts, followed by rapid freeze drying Powdered feed of freshwater eel shark is provided.
바람직하게, 상기 어란내용물은 가열처리에 의해 프로테아제(Protease)의 활성을 저감시키게 된다.Preferably, the content of the protein is reduced by protease activity by heat treatment.
또, 더욱 바람직하게는 상기 어란에서 피틴산(Phytic Acid))과 렉틴(Lectin)의 어란독을 제거하게 된다.In addition, more preferably, the phytase (Phytic Acid) and lectin (lectin) are removed from the egg.
유리하게, 상기 종합비타민은 열에 대해 취약한 성분을 고려하여 상기 어란내용물의 가열처리 후에 첨가된다.Advantageously, said multivitamin is added after the heat treatment of said raw contents, taking into account ingredients which are vulnerable to heat.
상기한 본 발명에 따른 민물뱀장어 자어의 분말사료에 의하면, 상어(특히, 곱상어)의 난황을 대신하여 해당하는 자어(렙토세팔루스)의 이동 해류의 범위에 서식하는 어종, 대표적으로 방어의 어란을 사용하기 때문에 사료의 저가화가 가능하게된다.According to the powdery feed of the freshwater eel's eardrarium fish according to the present invention, fish species inhabiting the range of migrating currents of a corresponding shark (leptosepalus) instead of the yolk of a shark (particularly, a shark fish) It is possible to reduce the cost of the feed.
또한, 상기 어란을 파쇄하여 필터링함으로써 난막이 제거된 상태의 어란내용물을 얻고 가열처리에 의해 프로테아제의 활성을 저감시키고 어란독을 제거함으로써 민물뱀장어 자어(렙토세팔루스)의 생잔율 및 성장율의 제고가 가능하게 된다.In addition, by breaking the eggs and filtering them, the contents of the egg shells in the state of removing the egg shells are obtained. By the heat treatment, the activity of the protease is reduced and the ooze poison is removed to improve the survival rate and growth rate of freshwater eel fish (leptosepalus) .
더욱이, 종합비타민제를 상기 어란내용물에 대한 가열처리가 이루어지고나서 혼합되도록 하기 때문에 비타민의 결핍에 의한 악영향이 배제되어 정상적인 성장 및 사료의 효율이 증가되게 된다.Furthermore, since the multivitamin preparation is allowed to be mixed with the contents after the heat treatment, the adverse effect due to the deficiency of vitamin is excluded and the normal growth and the efficiency of the feed are increased.
도 1은 본 발명의 바람직한 실시예에 따른 민물뱀장어 자어(렙토세팔루스)의 양식을 위한 식이조성물과 대조사료에 의한 시험어(자어)의 사육일수에 대한 생잔율을 대비하여 나타낸 그래프.Brief Description of the Drawings Fig. 1 is a graph showing the survival rate versus the number of days of rearing of test fishes (eared fishes) by a dietary composition and a control diet for freshwater eel fish (leptosepalus) culture according to a preferred embodiment of the present invention.
이하, 본 발명의 바람직한 실시예에 대해 상세하게 설명한다. Hereinafter, preferred embodiments of the present invention will be described in detail.
본 발명의 대상으로 되는 자어로는 실뱀장어로 변태되기 전의 프레렙토세파루스와 렙토세팔루스가 열거된다.Examples of the subject of the present invention include pre-ectoparasites and pre-ectoplasmic ectoplasm before they are transformed into eel.
또, 본 발명에서 상정하는 어류는 난생부화된 렙토세팔루스가 연안에 이르는 경로, 즉 북적도 해류와 쿠로시오 해류의 범위에서 서식하는 어종이 바람직한 바, 대표적으로는 천연 및 자연적으로 상당한 양의 어획이 가능한 방어(Seriola quinqueradiata)가 대표적으로 상정된다.In addition, the fish assumed in the present invention is preferably a fish species inhabited by the path of the re-hatching leptosepalus to the coast, that is, in the range of boreal currents and Kuroshio currents. Typically, Possible defenses (Seriola quinqueradiata) are assumed.
여기서, 본 발명에서는 식이조성물의 대표적인 어종으로서 방어가 상정되지만, 프레렙토세팔루스와 렙토세팔루스가 이동하는 해류의 범위에서 서식하는 어종의 어란이면 선택적으로 적용이 가능하게 된다.Herein, in the present invention, defense is assumed as a representative fish species of the dietary composition, but it is possible to selectively apply if the species is inhabited in the range of the ocean currents in which the pre-fetopocephalus and leptosepalus move.
그에 대해, 본 발명에 따라 자어(렙토세팔루스)의 사료를 얻기 위해 인위적으로 양식되거나 자연적으로 채획된 민물뱀장어에서 얻은 어란을 적용해도 된다..On the other hand, according to the present invention, eggs obtained from artificially cultivated or naturally-caught freshwater eels may be applied in order to obtain feeds of reptiles (leptosepalus).
대개, 어란은 난막(卵膜)과 그 난막에 의해 보호되는 내용물로 이루어지고, 그 어란은 난원세포(卵原細胞)의 증식기가 끝나면 난모세포(卵母細胞)로 되고, 난막형성 및 유구(油球)라든지 난황의 축적이 개시되는 성장기를 지나면서 성숙기로 진입된 후, 체외로 배란되기 까지는 해당하는 어류의 난소 내에 축적된다.Usually, eggs are composed of eggshell membranes and the contents protected by the egg shells. Eggs are oocyte cells after ovarian growth, Oil balls) or egg yolk accumulation is initiated, and then accumulated in the ovaries of the corresponding fish until it is in vitro fertilized.
따라서, 본 발명에서는 천연 또는 양식의 방어(또는 민물뱀장어)의 난소를 취출하여 얻은 생란(生卵)을 사용하거나, 염장가공란, 냉동란, 액상 또는 분말의 형태로 처리하여 사용하게 된다.Therefore, in the present invention, raw eggs obtained by extracting ovaries of natural or cultured defenses (or freshwater eel) are used, or processed in the form of salting, freezing, liquid or powder.
여기서, 상기의 어란은 그대로 다른 사료성분과 혼합해도 되지만, 균일성을 보장하여 항시 동일한 성질의 사료를 제조하기 위해서는 사료 제작 전에 어란을 파쇄하여 어란내용물을 얻어 다른 사료성분과 혼합해서 사용하게 된다.In order to ensure the uniformity and to always produce the same quality of feed, it is necessary to crush the eggs before the preparation of the feed to obtain the contents of the eggs and mix them with other feed ingredients.
즉, 상기의 어란내용물은 어체(魚體)의 어란을 파쇄하여 소정의 효소성분을 사용하거나 예컨대 100㎛급의 메쉬(Mesh)에 의해 필터링함으로써 난막을 제거함으로써 얻게 된다.That is, the above-mentioned contents of the egg can be obtained by crushing the fish eggs and removing the egg shell by using a predetermined enzyme component or by filtering with a mesh of, for example, 100 mu m grade.
여기서, 본 발명에 따르면 상기 식이조성물(사료)의 제조 시에는 예컨대 피틴산(Phytic Acid))이라든지 렉틴(Lectin)을 포함하여 민물뱀장어 자어(렙토세팔루스)의 성장을 저해하는 어란독(魚卵毒)을 제거해주어야만 유리하게 된다.According to the present invention, in the production of the dietary composition (feed) according to the present invention, it is possible to prevent the growth of a freshwater eel (leptosepalus) including a phytic acid or lectin, It is advantageous to remove it.
또한, 본 발명에 따르면 상기 어란내용물에 대해서는 프로테아제(Protease)의 활성을 저하시키는 처리가 바람직하게 되는 바, 그 프로테아제 활성 저감처리는 단백질 단백질 함량이 높은 조성물을 가열하는 경우 응고물이 생기게 되어 민물뱀장어 자어(렙토세팔루스)의 섭식에 지장을 준다는 점을 고려하여 응고물이 생기지 않도록 가열(바람직하게는 45∼70℃의 온도로 대략 40분)로 처리하거나 프로테아제 억제제(예컨대 동물성 유청(乳淸)이나 동물성 혈장(血漿) 등)를 첨가해서 행해지게 된다.In addition, according to the present invention, it is preferable to treat the above-mentioned contents with protease activity. In the protease activity reduction treatment, when a composition having a high protein protein content is heated, a solidified product is formed, (Preferably at a temperature of 45 to 70 캜 for about 40 minutes) or a protease inhibitor (for example, an animal whey protein) in order to prevent clotting, Or an animal plasma (plasma), etc.) is added.
또, 본 발명에 따르면 상기의 어란내용물에 대해 종합비타민이라든지 계란의 난백(또는 난백분말), 크릴새우 추출물 등의 첨가물을 혼합하여 사료(식이조성물)를 제조하게 된다.According to the present invention, a feed (dietary composition) is prepared by mixing multivitamin, egg white (or egg white powder), and an additive such as krill shrimp extract to the above-mentioned ingredients.
여기서, 상기 비타민은 양식어류의 건강유지와 생산활동의 개선 차원에서 필수적인 요소이지만 양식 수조 내에서는 상대적으로 섭취하기 어려운 환경이기 때문에 적절한 급여가 반드시 필요하게 된다.Here, the above vitamins are essential elements for the health maintenance and improvement of the production activities of the aquaculture fishes, but the environment is difficult to eat in the aquaculture tank, so proper payment is indispensable.
따라서, 본 발명에서 상기 종합비타민에는 결핍시 신경장애에 의한 체중감소와 성장지연, 폐사율 증가 등의 증상을 유발하는 비타민 B1(Thiamin)과, 부족시 시력손상과 수명현상 (photophobia)을 유발하는 비타민 B2(Riboflavin), 체내의 단백질 대사에 중요한 작용을 하고 비정상적인 수영활동, 호흡곤란, 폐사율증가 등의 결힙증상을 유발하는 비타민 B6(Pyridoxine), 부족시 사료섭취의 거부, 아가미조직의 이상 현상을 유발하는 판토텐산(Pantothenic acid), 결핍증상으로서 섭취량의 감소 및 사료효율의 감소를 유발하고 체색이 흑변(黑變)되는 현상을 유발하는 니아신(Niacin), 결핍시 피부병변, 근위축, 결장병변, 섭취량 감소, 경련 등의 증상 유발을 예방하기 위한 비오틴(Biotin)을 포함하게 된다.Therefore, in the present invention, the multivitamin includes vitamin B1 (Thiamin) which causes symptoms such as weight loss, growth retardation and mortality due to neuropathy at the time of deficiency, vitamins that cause blindness and photophobia B2 (Riboflavin), Vitamin B6 (Pyridoxine), which plays an important role in protein metabolism in the body and induces abnormal swimming activity, dyspnea and mortality such as increased mortality, rejection of feed intake during shortage, Pantothenic acid is a deficiency symptom. Niacin, which induces a decrease in intake and a decrease in feed efficiency, and a color change in black body, skin lesion in deficiency, muscle atrophy, colon lesion, intake (Biotin) to prevent the onset of symptoms such as depression, cramping and the like.
그에 더하여, 상기 종합비타민에는 특히 뱀장어류에서 결핍시 적혈구 미성숙에 의한 빈혈증상이라든지 성장률 감소를 유발하는 폴라신(Folacin), 정상적인 성장과 적혈구의 성숙 및 건강한 신경조직의 유지에 필요한 비타민 B12( cyanocobalamine), 결핍시 성장률 감소, 빈혈, 지느러미 괴사 등의 증상이 관찰되면서 특히 호화전분(Pre-gelatinized starch)가 높은 경우 증가된 양으로 첨가되는 이노시톨(Inositol)을 포함하게 된다.In addition, the multivitamins include folacin, which causes anemia due to erythrocyte immaturity in the absence of eel or lack of growth, vitamin B12 (cyanocobalamine) required for normal growth and erythrocyte maturation and healthy nerve tissue maintenance, , Inadequate growth rate, anemia, and fin necrosis, and inositol (inositol), which is added in an increased amount when the pre-gelatinized starch is high.
또한, 체내에서 메치오닌(methionine) 또는 베타인 (betaine)과 같은 메틸 공급원이 부족한 경우에는 지방의 신진대사작용에 필수적인 콜린(Choline)도 포함하게 된다.In addition, when the body lacks a methyl source such as methionine or betaine, it also contains choline, which is essential for fat metabolism.
또, 상기 종합비타민에는 정상적인 치아 및 뼈의 형성, 뼈의 손상회복, 상처치료, 콜라겐 및 연골의 형성에 중요한 기능을 하는 비타민 C도 포함되는 바, 콜라겐의 비정상적인 생성 또는 결핍 시에는 어류의 척추가 굽거나 좌우로 휘어지는 소위 '척추전만증(lordosis)'이나 척추측만증(scoliosis)'현상이 유발될 뿐만 아니라 아가미 사상체의 정상적인 형성이 저해되거나 주둥이나 턱의 모양이 변형되는 현상이 초래된다.In addition, the above-mentioned multivitamins also include vitamin C, which plays an important role in formation of normal teeth and bones, restoration of bone damage, wound healing, and formation of collagen and cartilage. In case of abnormal production or deficiency of collagen, This causes not only the so-called "lordosis" or scoliosis phenomenon that bend or bend to the left and right, but also the normal formation of the gill gouge is inhibited or the shape of the snout or jaw is deformed.
또, 상기 종합비타민에는 지용성의 비타민 A(A1, A2)가 포함되는 바, 비타민 A는 시각 작용에 중요한 역할을 하면서 결핍시 성장률이 저하되고 안구돌출증상이 초래된다, In addition, the multivitamin includes fat-soluble vitamin A (A1, A2), and vitamin A plays an important role in visual action,
또한, 상기 종합비타민에는 생물학적으로 활성을 나타내고 성장적인 골격의 정상적인 형성에 필요하며 비타민 D(D2, D3)도 포함되고, 결핍시 근육의 발육이상, 번식기관의 기능저하, 각막의 과산화물 손상에 대응하는 적혈구의 능력감소, 심한빈혈 현상 등이 유발되는 비타민 E. 수중의 어류에 중요한 정상적인 혈액응고율의 유지에 필요한 비타민 K도 포함된다. In addition, the multivitamin has biologically active and necessary for the normal formation of the growth skeleton. It also contains vitamin D (D2, D3), and it responds to deficiency of muscular dysfunction, reproductive organ function and corneal peroxide damage Vitamin K, which is necessary for the maintenance of normal blood coagulation rate, which is important for fish in the vitamin E. water, which is caused by a decrease in the ability of red blood cells and severe anemia.
바람직하게, 본 발명에 따르면, 상기의 종합비타민은 그 성분 중에 열에 취약한 요소도 포함되기 때문에, 해당하는 사료의 제조 시에는 상기 어란내용물의 프로테아제의 활성을 저감시키기 위한 가열처리를 행하고나서 혼합해주면 바람직하게 된다.Preferably, according to the present invention, the above-mentioned multivitamins also contain elements that are vulnerable to heat. Therefore, when the corresponding feed is prepared, it is preferable to carry out heat treatment to reduce the activity of the protease in the above- .
또, 상기 종합비타민에는 수분에 취약한 성분도 포함되기 때문에 해당하는 사료의 제조 시 냉동건조시켜 분말화해서 제조일로부터 2∼5일 이내에 급식이 이루어지도록 하면 바람직하게 된다.In addition, since the multivitamin contains a component susceptible to moisture, it is preferable to freeze and dry the powder during the production of the corresponding feed to allow the feed to be made within 2 to 5 days from the date of manufacture.
본 발명에 따르면, 상기 식이조성물(사료)는 상기 어란내용물 100중량%에 대해 상기 종합비타민은 5∼10중량∼%, 바람직하게는 6∼8중량%로 첨가되고, 상기 크릴새우 추출물은 10∼30중량, 바람직하게는 15∼20%로 첨가되며, 상기 계란의 난백은 5∼25중량%, 바람직하게는 10∼15중량%로 첨가되어 혼합되어 제조다.According to the present invention, the dietary composition (feed) is added in an amount of 5 to 10% by weight, preferably 6 to 8% by weight, of the multivitamin to 100% Preferably 15 to 20% by weight, and egg white of the egg is added in an amount of 5 to 25% by weight, preferably 10 to 15% by weight.
따라서, 상기한 본 발명에 따른 식이조성물(사료)에 대해 시험어의 성장/생잔을 시험하기 위해, 상기 식이조성물 25%에 증류수 75%를 교반기에 의해 교반하여 혼합하여 '사료 1'로 하는 반면 그 식이조성물(사료)에 대한 대조 사료는 상어란을 주원료로 하여 상어란 51%, 크릴새우분해물 5%, 증류수 44%로 혼합하여 '사료 2'를 제조하였다.Therefore, in order to test the growth / survival of the test fish on the dietary composition (feed) according to the present invention, 75% of distilled water was mixed with 25% of the dietary composition by stirring with a stirrer to make 'Feed 1' The feed for the dietary composition (shrimp) was prepared by mixing 51% shark egg, 5% krill shrimp, and 44% distilled water with shark egg as the main ingredient.
그리고, 양식산 친어로부터 난생부화된 예컨대 7일째 자어(렙토세팔루스) 300마리를 예컨대 10L 양식수조 3개에 분산 수용하여 상기 '사료 1'과 '사료 2' 및 무급식으로 사육하였다.For example, 300 horses (Leptosepalus), for example, 7 days old, which were hatched from cultured broodstock, were dispersed in three 10 L type water tanks for breeding with the above-mentioned "Feed 1" and "Feed 2".
여기서, 상기 '사료 1'과 '사료 2' 는 부화일로부터 8일째(즉, 사육개시일)부터 1일 3회, 사육수온은 24℃로 설정하였고, 사육개시일로부터 20일째까지 사육한 시점에서 전장과 생잔율을 측정하여 성장과 생육의 평가를 행하였다.The feed 1 and feed 2 were set three times a day from day 8 after the hatching (i.e., starting date of feeding), and the water temperature was set at 24 占 폚. And survival rate were measured to evaluate growth and growth.
도 1에 나타낸 바와 같이, 본 발명에 따른 '사료 1'을 급식한 양식수조의 시험어는 급격한 감소를 보이지 않 사육일로부터 12일째에서의 생잔율이 95%로, 대조사료인 '사료 2'의 80%에 비해 높은 경향을 보였다.As shown in FIG. 1, the test fish of the aquaculture tank fed with 'Feed 1' according to the present invention did not show a sharp decrease, and the survival rate at day 12 from the day of rearing was 95% 80%, respectively.
또, 그러한 경향은 사육개시일로부터 20일째까지 지속되어 생잔율이 40%를 보인 반면 '사료 2'의 31%에 비해 높은 생잔율을 유지하였다.This tendency was maintained until 20 days after the start of rearing, and the survival rate was 40%, while the survival rate was higher than 31% of 'Feed 2'.
그리고, 본 발명에 따른 사료 1을 급식한 양식수조 내의 시험어의 경우는 사육개시일로부터 20일이 경과하여 실뱀장어로의 변태 시까지 생존시킬 수 있었다.In the case of the test fish in the aquaculture tank fed with feed 1 according to the present invention, it was possible to survive until the transformation into the eel after 20 days from the start of rearing.
한편, 본 발명은 상기한 실시예로 한정되지는 않고 발명의 기술적 요지 및 요점을 이탈하지 않는 범위 내에서 다양한 변경 및 변형 실시가 가능하게 된다.
While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments.
Claims (3)
상기 식이조성물은 상기 자어가 연안으로 이동하는 해류의 범위에 서식하는 어종으로서의 방어의 어란을 파쇄하고 필터링하여 난막을 제거하여 얻어진 어란내용물에 종합비타민과 계란의 난백(卵白) 및 크릴새우 추출물을 혼합하여 급속냉동 건조시켜서 되는 것을 특징으로 하는 민물뱀장어 자어의 분말사료.In a dietary composition (feed) of a freshwater eel fed with a freshwater eel's Leptocephalus in a aquaculture tank,
The dietary composition is prepared by crushing and deflating defensive eggs as a fish species living in the range of the ocean currents migrating to the coast, and removing the egg shell, and then adding the multivitamin, eggs egg white and krill shrimp extract And then rapidly freeze-dried to obtain a powdery feed of fresh-caught eel.
상기 어란에서 피틴산(Phytic Acid))과 렉틴(Lectin)의 어란독을 제거한 것을 특징으로 하는 민물뱀장어 자어의 분말사료.The method according to claim 1, wherein the content of the protein is reduced by protease activity by heat treatment,
Wherein the fish eggs of the fish eggs are removed from the fish eggs of the above-mentioned fish eggs, and phytate (Phytic Acid) and lectins are removed from the fish eggs.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130057929A KR101548417B1 (en) | 2013-05-22 | 2013-05-22 | Feed composite for culturing leptocephalus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130057929A KR101548417B1 (en) | 2013-05-22 | 2013-05-22 | Feed composite for culturing leptocephalus |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140137244A true KR20140137244A (en) | 2014-12-02 |
KR101548417B1 KR101548417B1 (en) | 2015-08-28 |
Family
ID=52457178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130057929A KR101548417B1 (en) | 2013-05-22 | 2013-05-22 | Feed composite for culturing leptocephalus |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101548417B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108849645A (en) * | 2018-07-05 | 2018-11-23 | 湘阴县南湖洲镇七姑塘现代农业专业合作社 | A kind of freshwater fish culturing method |
CN112219758A (en) * | 2020-10-19 | 2021-01-15 | 中国水产科学研究院南海水产研究所 | Method for controlling sexual maturity of siganus oramin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4530248B2 (en) | 2003-06-26 | 2010-08-25 | 独立行政法人水産総合研究センター | Eel larvae feed |
JP5357830B2 (en) | 2010-05-14 | 2013-12-04 | 日本水産株式会社 | Eel larvae feed |
-
2013
- 2013-05-22 KR KR1020130057929A patent/KR101548417B1/en active IP Right Grant
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108849645A (en) * | 2018-07-05 | 2018-11-23 | 湘阴县南湖洲镇七姑塘现代农业专业合作社 | A kind of freshwater fish culturing method |
CN112219758A (en) * | 2020-10-19 | 2021-01-15 | 中国水产科学研究院南海水产研究所 | Method for controlling sexual maturity of siganus oramin |
Also Published As
Publication number | Publication date |
---|---|
KR101548417B1 (en) | 2015-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mercier et al. | Advances in marine biology: endogenous and exogenous control of gametogenesis and spawning in echinoderms | |
CN104542407B (en) | Two-stage cultivation method for loach offspring seeds | |
JP6986652B2 (en) | Amberjack farmed fish breeding method and yellowtail farmed fish | |
CN101933477A (en) | Artificial propagation method of Odontobutis obscura | |
CN102273416B (en) | Method for promoting synchronous development of sexual glands of takifugu obscurus male and female parent fishes | |
KR20140137508A (en) | Method for providing enhanced survival and growth of leptocephalus | |
CN107691877A (en) | A kind of preparation method of the fresh-water fishes microcapsules opening material of zero starch | |
JP6343804B2 (en) | Preparation and breeding method of finely ground zein-embedded taurine as bivalve floating larvae feed | |
Sverguzova et al. | Use of fly larvae Hermetia illucens in poultry feeding: a review paper | |
CN102919180B (en) | Artificial breeding method of sepia esculenta | |
KR101548417B1 (en) | Feed composite for culturing leptocephalus | |
CN104365538A (en) | Quasipaa spinosa tadpole breeding method | |
CN102792910B (en) | Cultivating method of oncorhynchus mykiss walbaum gynoecial hybrid offspring seed | |
CN102812913B (en) | Cultivation method for hybridized all-female golden trout fries | |
CN105901423B (en) | Method for domesticating hippocampus kelloggi to ingest compound feed | |
JPS6185151A (en) | Feed for honey bee and its production | |
KR101568463B1 (en) | Liquefied feed composite for culturing leptocephalus and method for fabricating the same | |
KR101568465B1 (en) | Solid feed composite for culturing leptocephalus and method for culturing leptosephalus by using the same | |
CN109480127A (en) | A kind of cray growth-promoting feed | |
CN107581398A (en) | A kind of preparation method of the salmon trout microcapsules opening material of zero starch | |
JP7248772B1 (en) | Seriola farmed fish and method for raising Seriola farmed fish | |
Ranjan et al. | Technology on seed production and culture of orange spotted grouper-A breakthrough for Indian mariculture | |
KR20220120825A (en) | Feed composition for mealworm and breeding method of mealworm using feed composition | |
Ondhoro et al. | Evaluation of the reproductive performance of African catfish (Clarias gariepinus) brood stock fed on three locally manufactured commercial feeds | |
CN114009619A (en) | Compound feed for young flamingo and brooding method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20190928 Year of fee payment: 5 |